Kathleen Gallagher

Corporate Officer/Principal presso AVIDITY BIOSCIENCES, INC.

Health Technology

Consumer Services

Posizioni attive di Kathleen Gallagher

Società	Posizione	Inizio	Fine
AVIDITY BIOSCIENCES, INC.	Corporate Officer/Principal	-	-
	Contatto Relazioni con gli Investitori	01/04/2021	-
	Public Communications Contact	01/04/2021	-

Società	Posizione	Inizio	Fine
MERRIMACK PHARMACEUTICALS, INC.	Public Communications Contact	01/01/2003	01/10/2016
AKCEA THERAPEUTICS, INC.	Contatto Relazioni con gli Investitori	-	-
AKCEA THERAPEUTICS, INC.	Public Communications Contact	-	-

Boston University

Undergraduate Degree

Distribuzione geografica

Stati Uniti	4
Israele	2

Posizioni

Public Communications Contact	3
Investor Relations Contact	2
Undergraduate Degree	1

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
MERRIMACK PHARMACEUTICALS, INC.	Health Technology
AVIDITY BIOSCIENCES, INC.	Health Technology

Aziende private	1
Akcea Therapeutics, Inc. Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Health Technology